Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
1991 Dec 01;1012:3805-17. doi: 10.1002/j.1460-2075.1991.tb04950.x.
Show Gene links
Show Anatomy links
The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
Schmitz ML
,
Baeuerle PA
.
???displayArticle.abstract???
The nuclear form of the NF-kappa B transcription factor binds to DNA as a heterodimer of a 50 kDa (p50) and 65 kDa (p65) polypeptide. The two polypeptides are encoded by different genes but share a long region of homology, the NRD motif, encompassing domains required for DNA binding and dimerization. In this study we have analysed the contribution of the two subunits to the strong transactivating potential of NF-kappa B. Transient expression of the p65 subunit alone resulted in a potent transactivation of a CAT reporter construct under the control of two NF-kappa B binding sites in monkey COS and mouse L cells. The strongly DNA binding p50 subunit showed only very weak, if any, induction of gene expression. Co-expression of p50 suppressed the transactivation by p65 presumably by competitive DNA binding of transcriptionally inactive p50 dimers (KBF1). Fusion of p65 sequences to DNA binding domain of the yeast GAL4 transcription factor allowed detection of the principal transactivation domain of p65 (TA1) in the C-terminal 30 amino acid sequence. TA1 is likely to adopt an amphipathic alpha-helical structure which clusters serine residues on the hydrophilic surface, a structural feature conserved between human, mouse and Xenopus p65. The unique C-terminal third of p65 contained at least one more activation domain, TA2, within a 90 amino acid sequence directly adjacent to TA1. In two mammalian cell lines, TA1 and TA2 acted separately, while in an insect cell line, the two domains were inactive after their separation. Our study suggests that the p50 subunit in NF-kappa B might only serve a helper function in DNA binding whereas the p65 subunit is responsible for initiating transcription. Homodimers of p50 seem to have the potential of down-regulating kappa B-specific gene expression.
Baeuerle,
I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
1988, Pubmed
Baeuerle,
I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
1988,
Pubmed
Baeuerle,
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
1989,
Pubmed
Baeuerle,
The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.
1991,
Pubmed
Bours,
Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.
1990,
Pubmed
Bradford,
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
1976,
Pubmed
Brownell,
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.
1989,
Pubmed
Bull,
The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.
1990,
Pubmed
Carey,
An amino-terminal fragment of GAL4 binds DNA as a dimer.
1989,
Pubmed
Chou,
Prediction of the secondary structure of proteins from their amino acid sequence.
1978,
Pubmed
Clark,
Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer.
1990,
Pubmed
Cress,
Critical structural elements of the VP16 transcriptional activation domain.
1991,
Pubmed
Garnier,
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.
1978,
Pubmed
Ghosh,
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
1990,
Pubmed
Gilmore,
v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells.
1988,
Pubmed
Gilmore,
NF-kappa B, KBF1, dorsal, and related matters.
1990,
Pubmed
Giniger,
Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.
,
Pubmed
Govind,
Dorsoventral pattern formation in Drosophila: signal transduction and nuclear targeting.
1991,
Pubmed
Inoue,
c-rel activates but v-rel suppresses transcription from kappa B sites.
1991,
Pubmed
Ip,
The dorsal morphogen is a sequence-specific DNA-binding protein that interacts with a long-range repression element in Drosophila.
1991,
Pubmed
Israël,
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes.
1987,
Pubmed
Israël,
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors.
1989,
Pubmed
Kao,
Expression of a mRNA related to c-rel and dorsal in early Xenopus laevis embryos.
1991,
Pubmed
,
Xenbase
Kawakami,
Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
1988,
Pubmed
Kerr,
The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
1991,
Pubmed
Kieran,
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
1990,
Pubmed
Landschulz,
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.
1988,
Pubmed
Lenardo,
NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity.
1988,
Pubmed
Logeat,
Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant.
1991,
Pubmed
Lopata,
High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment.
1984,
Pubmed
Maizel,
Enhanced graphic matrix analysis of nucleic acid and protein sequences.
1981,
Pubmed
Meyer,
Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.
1991,
Pubmed
Mitchell,
Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.
1989,
Pubmed
Nolan,
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
1991,
Pubmed
Pierce,
Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.
1988,
Pubmed
Ptashne,
How eukaryotic transcriptional activators work.
1988,
Pubmed
Ptashne,
Gene regulation by proteins acting nearby and at a distance.
,
Pubmed
Richardson,
vRel is an inactive member of the Rel family of transcriptional activating proteins.
1991,
Pubmed
Rivière,
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
1991,
Pubmed
Ruben,
Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
1991,
Pubmed
Sadowski,
GAL4-VP16 is an unusually potent transcriptional activator.
1988,
Pubmed
Schreck,
The NF-kappa B transcription factor induces DNA bending which is modulated by its 65-kD subunit.
1990,
Pubmed
Silver,
Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization.
1984,
Pubmed
Struhl,
Promoters, activator proteins, and the mechanism of transcriptional initiation in yeast.
1987,
Pubmed
Triezenberg,
Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression.
1988,
Pubmed
Urban,
NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.
1991,
Pubmed
Urban,
The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity.
1990,
Pubmed
Urban,
The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences.
1991,
Pubmed
Wigler,
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.
1978,
Pubmed
Zabel,
Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA.
1990,
Pubmed
